Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers
US-12180259-B2 · Dec 31, 2024 · US
This page is not indexed by search engines while we improve data quality.
Mueller Phillip patents
Mueller Phillip is listed as an inventor on 68 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Mueller Phillip |
| Total patents | 68 |
| First publication | Sep 1, 2016 |
| Latest publication | Dec 31, 2024 |
Notable patents
Publications ranked by popularity score, then publication date.
Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (hcc) and other cancers
US-2024408166-A1 · Dec 12, 2024 · US
Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers
US-12144852-B2 · Nov 19, 2024 · US
Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers
US-12121572-B2 · Oct 22, 2024 · US
Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers
US-12102670-B2 · Oct 1, 2024 · US
Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers
US-12097249-B2 · Sep 24, 2024 · US
Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers
US-12097248-B2 · Sep 24, 2024 · US
Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers
US-12076380-B2 · Sep 3, 2024 · US
Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers
US-12076381-B2 · Sep 3, 2024 · US
Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers
US-12070491-B2 · Aug 27, 2024 · US
Recent patents
Latest publications not already listed above.
Novel peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers
US-2024016908-A1 · Jan 18, 2024 · US
Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers
US-11826409-B2 · Nov 28, 2023 · US
Peptides and combination of peptides for use in immunotherapy against Hepatocellular carcinoma (HCC) and other cancers
US-11786583-B2 · Oct 17, 2023 · US
Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers
US-11786584-B2 · Oct 17, 2023 · US
Method of eliciting a CD8+ cytotoxic response in hepatocellular carcinoma patients with a population of activated T cells
US-11779638-B2 · Oct 10, 2023 · US
Method of eliciting a CD8+ cytotoxic response in hepatocellular carcinoma patients with a population of activated T cells
US-11679147-B2 · Jun 20, 2023 · US
Method of eliciting a CD8+ cytotoxic response in hepatocellular carcinoma patients with a population of activated T cells
US-11672848-B2 · Jun 13, 2023 · US
Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers
US-11576956-B2 · Feb 14, 2023 · US
Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (hcc) and other cancers
US-2023031307-A1 · Feb 2, 2023 · US
Method of eliciting a CD8+ cytotoxic response in hepatocellular carcinoma patients with a population of activated T cells
US-11559573-B2 · Jan 24, 2023 · US
Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (hcc) and other cancers
US-2022354939-A1 · Nov 10, 2022 · US
Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (hcc) and other cancers
US-2022339272-A1 · Oct 27, 2022 · US
Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (hcc) and other cancers
US-2022257739-A1 · Aug 18, 2022 · US
Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers
US-11406693-B2 · Aug 9, 2022 · US
Novel peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers
US-2022152171-A1 · May 19, 2022 · US
Novel peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers
US-2022152175-A1 · May 19, 2022 · US
Novel peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers
US-2022143163-A1 · May 12, 2022 · US
Novel peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers
US-2022143162-A1 · May 12, 2022 · US
Novel peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers
US-2022143164-A1 · May 12, 2022 · US
Novel peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers
US-2022133870-A1 · May 5, 2022 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Immatics Biotechnologies Gmbh | 68 |
| immatics biotechnology GmbH | 2 |
| Immatics Biotechologies Gmbh | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C12N2310/16 | 68 |
| C12N15/115 | 68 |
| C07K14/7051 | 68 |
| C07K7/08 | 68 |
| C07K7/06 | 68 |